PRICE T ROWE ASSOCIATES INC /MD/
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,058,970
+$859,889 QoQ
Shares Held
305,897
+32.4% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. BCRX ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
68,214,436 | $1,083,245,243 | |
| 2 | ALKS |
Alkermes plc.
|
6,737,328 | $353,035,986 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,903,354 | $211,158,092 | |
| 4 | LQDA |
Liquidia Corp
|
1,940,364 | $154,705,221 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
243,444 | $131,905,262 | |
| 6 | PRGO |
PERRIGO Co plc
|
8,700,421 | $90,397,373 | |
| 7 | ZTS |
Zoetis Inc.
|
1,139,097 | $81,855,510 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,679,152 | $56,889,668 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,058,970 | 305,897 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,199,081 | 230,996 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,383,657 | 177,392 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,224,631 | 161,348 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,313,885 | 146,639 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,007,212 | 134,295 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $953,581 | 126,806 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,120,892 | 2,252,749 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,044,720 | 1,948,984 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $664,337 | 130,775 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $680,967 | 113,684 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $738,550 | 104,315 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $674,727 | 95,842 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $728,315 | 87,328 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $962,299 | 83,824 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,029,659 | 81,719 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $805,624 | 76,146 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,317,206 | 81,009 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,216,653 | 87,845 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,348,725 | 93,857 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,457,144 | 92,166 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $976,218 | 95,990 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $650,720 | 87,345 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $120,795 | 35,115 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $52,883 | 11,110 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $20,588 | 10,294 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||